Background: Preeclampsia is a rapidly progressing pregnancy-specific multi-systemic syndrome that is the leading cause of maternal and neonatal morbidity and mortality. Lactate dehydrogenase (LDH) is a valuable and potential biomarker for predicting the severity of Preeclampsia.

Objectives: To assess the level of LDH in women with preeclampsia and to correlate its level with the severity of the disease and maternal/perinatal outcomes.

Patients And Methods: This prospective case-control study was conducted at Sulaimani Maternity Teaching Hospital, Sulaimaniyah, Iraq, from March 1st, 2021, to June 30th, 2022, on 150 pregnant women in 3rd trimester of their pregnancy. Patients (n = 100) were diagnosed with mild and severe Preeclampsia. Serum LDH level was measured and correlated with the severity of the disease and maternal/perinatal outcomes.

Results: LDH was significantly (p = 0.001) elevated in preeclampsia groups compared to the control group. The mild preeclampsia group had a mean LDH level of 302.9 ± 138.5 IU/L, while the severe preeclampsia group had a mean level of 488.6 ± 223.4 IU/L. Also, maternal complications, stillbirth rate, and neonatal intensive Care Unit (NICU) admission were higher in women with high LDH levels.

Conclusions: The serum LDH level is high in women with preeclampsia and correlated with the disease severity as well as maternal and perinatal outcomes. So, serum LDH may be a valuable biomarker for predicting the severity of preeclampsia.

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12905-025-03622-5DOI Listing

Publication Analysis

Top Keywords

serum ldh
12
ldh level
12
preeclampsia
9
lactate dehydrogenase
8
disease severity
8
maternal perinatal
8
perinatal outcomes
8
ldh
8
ldh valuable
8
biomarker predicting
8

Similar Publications

Article Synopsis
  • The study focused on β2-microglobulin (β2-MG) as a predictor of prognosis in patients with diffuse large B-cell lymphoma (DLBCL), involving 98 patients over two years.
  • The critical threshold for β2-MG was identified as 3.285 µg/L, with patients below this level showing better survival rates compared to those above it during follow-up.
  • Elevated levels of β2-MG, along with LDH and CRP, were determined to be independent risk factors influencing overall survival in DLBCL patients, leading to the development of a prognostic prediction model that effectively correlated predicted outcomes with actual results.
View Article and Find Full Text PDF

Background: Preeclampsia is a rapidly progressing pregnancy-specific multi-systemic syndrome that is the leading cause of maternal and neonatal morbidity and mortality. Lactate dehydrogenase (LDH) is a valuable and potential biomarker for predicting the severity of Preeclampsia.

Objectives: To assess the level of LDH in women with preeclampsia and to correlate its level with the severity of the disease and maternal/perinatal outcomes.

View Article and Find Full Text PDF

Aim: Ginsenosides have notable bioactivity in treating cardiovascular diseases, but the mechanisms of their combined use with Peroxiredoxin 6 (PRDX6) in myocardial injury remain unclear. This study explores the synergistic effects of Ginsenoside Rb1 (Gs-Rb1) and PRDX6, aiming to provide a theoretical foundation for their therapeutic potential.

Methods: We established a rat model of isoproterenol (ISO)-induced myocardial injury and observed that combination therapy was more effective than single-drug treatments, as shown by ECG monitoring and Masson staining.

View Article and Find Full Text PDF

Resveratrol improves gasdermin D-mediated pyroptosis of vascular endothelial cells induced by a high-fat diet and palmitic acid possibly via the SIRT1-p66Shc-NLRP3 pathway.

J Nutr Biochem

March 2025

Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Anhui Medical University, No.81, Plum Hill Road, Hefei 230032, China; The Comprehensive Experimental Center, School of Basic Medical Sciences, Anhui Medical University, No.81, Plum Hill Road, Hefei 230032, China. Electronic address:

Resveratrol (RSV) ameliorates endothelial dysfunction (ED) primarily through sirtuin 1 (SIRT1). Increasing evidence shows pyroptosis as a novel mechanism in palmitic acid (PA)-induced ED. p66Shc is an adaptor protein involved in oxidative stress.

View Article and Find Full Text PDF

Ga-68 Pentixafor PET/CT in multiple myeloma and its correlation with clinical parameters: institutional pilot study.

Ann Nucl Med

March 2025

Department of Nuclear Medicine, Apollo Hospitals, Greams Lane, 21, Greams Road, Thousand Lights, Chennai, Tamil Nadu, 600006, India.

Objective: This study evaluates the role of Ga-68 Pentixafor PET/CT in staging and follow-up of multiple myeloma (MM) and its correlation with clinical parameters.

Methods: Thirteen participants (9 males, 4 females; median age: 65 years) with MM were recruited in this prospective observational study. Six participants were included for staging evaluation, seven were included for follow-up evaluation, and underwent Ga-68 Pentixafor PET/CT.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!